ISSN 2147-9720 | E-ISSN 2148-4279
RELATED ARTICLES
Case Report
Presentation of three cases followed up with a diagnosis of Felty syndrome
(Eur J Rheumatol 2014; 1: 120-122)
DOI: 10.5152/eurjrheumatol.2014.026
Methorexate therapy in a patient with rheumatoid arthritis complicated by idiopathic thrombocytopenic purpura
(Eur J Rheumatol 2015; 2: 39-40)
DOI: 10.5152/eurjrheumatol.2014.14065
A severe case of systemic lupus erythematosus with increased pressure communicating hydrocephalus
(Eur J Rheumatol 2015; 2: 76-77)
DOI: 10.5152/eurjrheum.2015.0084
Inflammatory myopathy and autoimmune hepatitis in a patient with a flare of systemic lupus erythematosus: An exceptional association
(Eur J Rheumatol 2018; 5: 197-200)
DOI: 10.5152/eurjrheum.2018.17135
Hemophagocytic lymphohistiocytosis after certolizumab treatment in a patient with rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 203-205)
DOI: 10.5152/eurjrheum.2018.17108
Spontaneous patellar tendon rupture in a case followed up for diagnosis of systemic lupus erythematosus
(Eur J Rheumatol 2014; 1: 159-160)
DOI: 10.5152/eurjrheumatol.2014.140044
A case of systemic lupus erythematosus with multiple nodules in the bilateral lungs and vertebrae
(Eur J Rheumatol 2016; 3: 38-40)
DOI: 10.5152/eurjrheum.2015.0026
Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?
(Eur J Rheumatol 2017; 4: 57-58)
DOI: 10.5152/eurjrheum.2017.160058
Rheumatoid arthritis and tabetic arthropathy: physiopathological link or simple association?
(Eur J Rheumatol 2016; 3: 41-43)
DOI: 10.5152/eurjrheum.2015.0006
Hydroxychloroquine-induced agranulocytosis in a patient with long-term rheumatoid arthritis
(Eur J Rheumatol 2016; 3: 91-92)
DOI: 10.5152/eurjrheum.2015.0028
Severe candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab
(Eur J Rheumatol 2014; 1: 167-169)
DOI: 10.5152/eurjrheumatol.2014.140001
A case of central nervous system nocardiosis in a patient with lupus treated with belimumab
(Eur J Rheumatol 2016; 3: 188-190)
DOI: 10.5152/eurjrheum.2016.15083
Aneurysm of the ascending aorta in systemic lupus erythematosus: Case report and review of the literature
(Eur J Rheumatol 2017; 4: 133-135)
DOI: 10.5152/eurjrheum.2017.17066
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome
(Eur J Rheumatol 2018; 5: 272-274)
DOI: 10.5152/eurjrheum.2018.18040
Atrial fibrillation following therapy with high-dose i.v. methylprednisolone: A brief case-based review
(Eur J Rheumatol 2017; 4: 231-233)
DOI: 10.5152/eurjrheum.2017.16120
Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature
(Eur J Rheumatol 2017; 4: 139-141)
DOI: 10.5152/eurjrheum.2017.16066
Cavitary pulmonary nodules in rheumatoid arthritis; case reports and review of the literature
(Eur J Rheumatol 2018; 5: 65-68)
DOI: 10.5152/eurjrheum.2017.16106
A report of three cases with lupus myelitis
(Eur J Rheumatol 2017; 4: 148-150)
DOI: 10.5152/eurjrheum.2017.160099
A rare cause of cytopenia in a patient with systemic lupus erythematosus: Autoimmune myelofibrosis
(Eur J Rheumatol 2017; 4: 76-78)
DOI: 10.5152/eurjrheum.2016.011
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18040
Hemophagocytic lymphohistiocytosis after certolizumab treatment in a patient with rheumatoid arthritis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17108
Inflammatory myopathy and autoimmune hepatitis in a patient with a flare of systemic lupus erythematosus: An exceptional association
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17135
Original Article
IL-1A gene variation in relation to cytokine levels and clinical characteristics in ankylosing spondylitis
(Eur J Rheumatol 2019; 6: 67-70)
DOI: 10.5152/eurjrheum.2018.18150
Serum hepcidin level and rheumatoid arthritis disease activity
(Eur J Rheumatol 2019; 6: 76-80)
DOI: 10.5152/eurjrheum.2018.18114
Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis
(Eur J Rheumatol 2019; 6: 81-84)
DOI: 10.5152/eurjrheum.2019.18109
Muscle loss following a single high-dose intramuscular injection of corticosteroids to treat disease flare in patients with rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 160-164)
DOI: 10.5152/eurjrheum.2018.17148
Is rheumatoid arthritis an innocent bystander in female reproductive problems? A comparative study of fertility in Nigerian women with and without rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 179-183)
DOI: 10.5152/eurjrheum.2018.17180
Risk factor assessment of rheumatoid arthritis in North Kerala
(Eur J Rheumatol 2018; 5: 184-190)
DOI: 10.5152/eurjrheum.2018.17111
Sarcopenia in women with rheumatoid arthritis
(Eur J Rheumatol 2015; 2: 57-61)
DOI: 10.5152/eurjrheum.2015.0038
Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers
(Eur J Rheumatol 2015; 2: 62-65)
DOI: 10.5152/eurjrheum.2015.0101
Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis
(Eur J Rheumatol 2016; 3: 106-108)
DOI: 10.5152/eurjrheum.2016.15096
The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients
(Eur J Rheumatol 2016; 3: 109-117)
DOI: 10.5152/eurjrheum.2016.16002
Humor in systemic lupus erythematosus
(Eur J Rheumatol 2015; 2: 5-9)
DOI: 10.5152/eurjrheumatol.2015.0070
Prevalence of the metabolic syndrome in rheumatoid arthritis
(Eur J Rheumatol 2014; 1: 1-4)
DOI: 10.5152/eurjrheum.2014.001
Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis
(Eur J Rheumatol 2014; 1: 14-17)
DOI: 10.5152/eurjrheum.2014.004
Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study
(Eur J Rheumatol 2014; 1: 51-54)
DOI: 10.5152/eurjrheumatol.2014.018
Mental health status can reflect disease activity in rheumatoid arthritis
(Eur J Rheumatol 2014; 1: 55-57)
DOI: 10.5152/eurjrheumatol.2014.020
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study
(Eur J Rheumatol 2014; 1: 67-71)
DOI: 10.5152/eurjrheumatol.2014.022
The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus
(Eur J Rheumatol 2014; 1: 92-95)
DOI: 10.5152/eurjrheumatol.2014.032
Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning
(Eur J Rheumatol 2016; 3: 44-49)
DOI: 10.5152/eurjrheum.2015.0055
Changes in sirtuin 2 and sirtuin 3 mRNA expressions in rheumatoid arthritis
(Eur J Rheumatol 2017; 4: 83-86)
DOI: 10.5152/eurjrheum.2017.16056
Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2019.18195
Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 85-91)
DOI: 10.5152/eurjrheum.2018.17113
Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology
(Eur J Rheumatol 2018; 5: 92-95)
DOI: 10.5152/eurjrheum.2018.17105
Serological screening for celiac disease in children with systemic lupus erythematosus
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2019.18130
Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing
(Eur J Rheumatol 2015; 2: 135-138)
DOI: 10.5152/eurjrheum.2015.0012
Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance
(Eur J Rheumatol 2014; 1: 135-139)
DOI: 10.5152/eurjrheumatol.2014.140046
Surgery for lumbar spinal stenosis in patients with rheumatoid arthritis: A multicenter observational study
(Eur J Rheumatol 2016; 3: 56-60)
DOI: 10.5152/eurjrheum.2016.15070
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy
(Eur J Rheumatol 2019; 6: 19-22)
DOI: 10.5152/eurjrheum.2018.18096
Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?
(Eur J Rheumatol 2018; 5: 22-26)
DOI: 10.5152/eurjrheum.2018.17021
A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis
(Eur J Rheumatol 2019; 6: 23-28)
DOI: 10.5152/eurjrheum.2018.18078
Evaluating disease activity in patients with ankylosing spondylitis and rheumatoid arthritis using 99mtc-glucosamine
(Eur J Rheumatol 2016; 3: 65-72)
DOI: 10.5152/eurjrheum.2016.15074
Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone
(Eur J Rheumatol 2014; 1: 147-149)
DOI: 10.5152/eurjrheumatol.2014.140074
IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role
(Eur J Rheumatol 2017; 4: 29-35)
DOI: 10.5152/eurjrheum.2017.16059
Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis
(Eur J Rheumatol 2019; 6: 29-33)
DOI: 10.5152/eurjrheum.2018.18099
Case series: Monoarticular rheumatoid arthritis
(Eur J Rheumatol 2017; 4: 264-267)
DOI: 10.5152/eurjrheum.2017.17011
Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus
(Eur J Rheumatol 2018; 5: 244-248)
DOI: 10.5152/eurjrheum.2018.18074
A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment
(Eur J Rheumatol 2018; 5: 111-114)
DOI: 10.5152/eurjrheum.2018.17147
Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes
(Eur J Rheumatol 2018; 5: 32-36)
DOI: 10.5152/eurjrheum.2017.17088
Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis
(Eur J Rheumatol 2017; 4: 40-45)
DOI: 10.5152/eurjrheum.2017.16052
The new ACR/EULAR criteria for rheumatoid arthritis can identify patients with same disease activity but less damage by ultrasound
(Eur J Rheumatol 2017; 4: 118-121)
DOI: 10.5152/eurjrheum.2017.160091
Outcomes of rituximab therapy in refractory lupus: A meta-analysis
(Eur J Rheumatol 2018; 5: 118-126)
DOI: 10.5152/eurjrheum.2018.17096
Serum hepcidin level and rheumatoid arthritis disease activity
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18114
Rheumatoid Arthritis: Are psychological factors effective in disease flare?
(Eur J Rheumatol 2017; 4: 127-132)
DOI: 10.5152/eurjrheum.2017.16100
IL-1A gene variation in relation to cytokine levels and clinical characteristics in ankylosing spondylitis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18150
Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18099
Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18074
Risk factor assessment of rheumatoid arthritis in North Kerala
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17111
Is rheumatoid arthritis an innocent bystander in female reproductive problems? A comparative study of fertility in Nigerian women with and without rheumatoid arthritis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17180
Muscle loss following a single high-dose intramuscular injection of corticosteroids to treat disease flare in patients with rheumatoid arthritis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17148
Outcomes of rituximab therapy in refractory lupus: a meta-analysis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17096
Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17113
A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17147
Invited Review
Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: New insights and review
(Eur J Rheumatol 2018; 5: 127-130)
DOI: 10.5152/eurjrheum.2017.17198
Pre-rheumatoid arthritis and its prevention
(Eur J Rheumatol 2017; 4: 161-165)
DOI: 10.5152/eurjrheum.2017.16006
Literature Review
Carbamazepine-induced systemic lupus erythematosus: A case-based review
(Eur J Rheumatol 2019; 6: 48-54)
DOI: 10.5152/eurjrheum.2018.18046
Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures
(Eur J Rheumatol 2017; 4: 151-156)
DOI: 10.5152/eurjrheum.2016.035
Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?
(Eur J Rheumatol 2017; 4: 157-160)
DOI: 10.5152/eurjrheum.2016.039
Case based Review
Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab: A case report and literature review
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2019.17169
Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2019 Medical Research and Education Association | Latest Update: 08.04.2019